| Parkinson’s Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life R Scherbaum, E Hartelt, M Kinkel, R Gold, S Muhlack, L Tönges Journal of neurology 267 (4), 954-965, 2020 | 48 | 2020 |
| Clinical profiles and mortality of COVID‐19 inpatients with Parkinson's disease in Germany R Scherbaum, EH Kwon, D Richter, D Bartig, R Gold, C Krogias, ... Movement Disorders 36 (5), 1049-1057, 2021 | 43 | 2021 |
| Dynamics of Parkinson’s disease multimodal complex treatment in Germany from 2010–2016: Patient characteristics, access to treatment, and formation of regional centers D Richter, D Bartig, S Muhlack, E Hartelt, R Scherbaum, AH Katsanos, ... Cells 8 (2), 151, 2019 | 39 | 2019 |
| Parkinson’s disease multimodal complex treatment (PD-MCT): analysis of therapeutic effects and predictors for improvement E Hartelt, R Scherbaum, M Kinkel, R Gold, S Muhlack, L Tönges Journal of clinical medicine 9 (6), 1874, 2020 | 18 | 2020 |
| Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany D Richter, R Scherbaum, D Bartig, R Gold, C Krogias, L Tönges Parkinsonism & Related Disorders 85, 109-113, 2021 | 14 | 2021 |
| Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study R Scherbaum, A Moewius, J Oppermann, J Geritz, C Hansen, R Gold, ... Journal of Neurology, 2022 | 7 | 2022 |
| Hospital admissions for neurodegenerative diseases during the first wave of the COVID-19 pandemic: A nationwide cross-sectional study from Germany R Scherbaum, EH Kwon, D Richter, D Bartig, R Gold, C Krogias, L Tönges Brain Sciences 11 (9), 1219, 2021 | 7 | 2021 |
| Prevalence and characteristics of polyneuropathy in atypical Parkinsonian syndromes: An explorative study R Rohmann, E Kühn, R Scherbaum, L Hilker, S Kools, L Scholz, K Müller, ... Brain Sciences 11 (7), 879, 2021 | 5 | 2021 |
| COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany R Scherbaum, D Bartig, D Richter, EH Kwon, S Muhlack, R Gold, ... Neurological Research and Practice 4 (1), 27, 2022 | 1 | 2022 |
| Assessing Decision-Making Skills with the Script Concordance Test (SCT) in Clinical Neurology and Emergency Medicine HF Gudorf, M Heidrich, K Rauchstädt, R Scherbaum, L Tönges, ... | | 2024 |
| Longitudinal evaluation of polyneuropathy in Parkinson’s disease EH Kwon, A Bieber, P Schülken, K Müller, E Kühn, P Averdunk, S Kools, ... Journal of Neurology, 1-11, 2024 | | 2024 |
| Multidisciplinary Complex Treatment of Parkinson's disease: Cornerstone of an individualized treatment R Scherbaum, L Tönges Der Nervenarzt, 2024 | | 2024 |
| Data-driven subtyping of Parkinson’s disease: comparison of current methodologies and application to the Bochum PNS cohort Q Chen, R Scherbaum, R Gold, K Pitarokoili, A Mosig, S Zella, L Tönges Journal of Neural Transmission 130 (6), 763-776, 2023 | | 2023 |
| Clinical and device-based predictors of improvement in motor experiences of daily living after a short-term multidisciplinary inpatient treatment: a cohort study [abstract] R Scherbaum, J Oppermann, A Moewius, V Tschentscher, J Geritz, ... Movement Disorders 37, S132-S133, 2022 | | 2022 |
| Gangstörung und Muskelschmerzen R Scherbaum, L Tönges Neurodegeneration–35 Fallbeispiele aus der Praxis, 3-10, 2022 | | 2022 |
| Der Einfluss der multidisziplinären Parkinson-Komplextherapie auf Lebensqualität, motorische Symptome und Depressivität bei Patienten mit idiopathischem Parkinson-Syndrom R Scherbaum | | 2021 |
Lars TöngesProfessor of Neurology, Ruhr-University BochumVerified email at rub.de
